Profile
Thomas Lander formerly worked at CureVac SE, as Managing Director, Allergy Therapeutics Plc, as Independent Non-Executive Director from 2012 to 2017, vasopharm GmbH, as Director-Supervisory Board, Tuebingen Scientific Medical GmbH, as Managing Director, Lipid Therapeutics GmbH, as Non-Executive Director, Merck KGaA, as Chief Medical Officer, Novo Nordisk A, as Principal, and Boehringer Ingelheim AB, as Principal.
Former positions of Thomas Lander
Companies | Position | End |
---|---|---|
ALLERGY THERAPEUTICS PLC | Director/Board Member | 2017-06-29 |
MERCK KGAA | Chief Tech/Sci/R&D Officer | - |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Director/Board Member | - |
Tuebingen Scientific Medical GmbH
Tuebingen Scientific Medical GmbH Medical SpecialtiesHealth Technology Tuebingen Scientific Medical GmbH develops, produces and markets instruments and accessories for minimally invasive surgery. The company was founded by Marc O. Schurris in 2001 and is headquartered in Tübingen, Germany. | Corporate Officer/Principal | - |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
NOVO NORDISK A/S | Health Technology |
ALLERGY THERAPEUTICS PLC | Health Technology |
MERCK KGAA | Health Technology |
Private companies | 5 |
---|---|
Lipid Therapeutics GmbH
Lipid Therapeutics GmbH Medical/Nursing ServicesHealth Services Lipid Therapeutics GmbH develops therapies for inflammatory diseases of the digestive system. Its product is LT-02, a delayed release of Phosphatidylcholine, for the treatment of Ulcerative colitis based on the preclinical and clinical work conducted by Prof. Stremmel from the University Hospital Heidelberg. The company was founded in 2008 and is headquartered in Heidelberg, Germany. | Health Services |
Boehringer Ingelheim AB
Boehringer Ingelheim AB Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim AB develops, produces, markets and sells pharmaceutical products. The firm also provides research, development, manufacturing and marketing services in the therapeutic field of human and veterinary medicine. The company was founded in 1967 is headquartered in Stockholm, Germany. | Health Technology |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Tuebingen Scientific Medical GmbH
Tuebingen Scientific Medical GmbH Medical SpecialtiesHealth Technology Tuebingen Scientific Medical GmbH develops, produces and markets instruments and accessories for minimally invasive surgery. The company was founded by Marc O. Schurris in 2001 and is headquartered in Tübingen, Germany. | Health Technology |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Health Technology |
- Stock Market
- Insiders
- Thomas Lander